Double maintains 1 strategies that include PBYI - Puma Biotechnology, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AWK | 0.01% | $27.95B | +5.15% | 2.18% |
VIV | -0.01% | $18.00B | +28.81% | 0.69% |
DUK | 0.20% | $91.66B | +11.97% | 3.55% |
STG | 0.25% | $56.15M | +27.66% | 0.00% |
B | 0.28% | $36.52B | +15.69% | 1.88% |
AU | 0.29% | $24.15B | +65.64% | 2.14% |
HTHT | 0.33% | $9.93B | +2.52% | 2.99% |
NEM | -0.35% | $67.69B | +28.45% | 1.68% |
SPNS | -0.37% | $1.66B | -21.71% | 1.98% |
QFIN | 0.37% | $5.49B | +114.97% | 3.03% |
PM | 0.44% | $281.34B | +72.03% | 3.00% |
TME | 0.46% | $14.46B | +39.10% | 0.85% |
PGR | -0.49% | $145.01B | +13.94% | 1.99% |
AXON | -0.53% | $58.41B | +143.09% | 0.00% |
MNOV | 0.58% | $62.78M | -9.86% | 0.00% |
TFX | 0.61% | $5.11B | -47.35% | 1.17% |
KGC | 0.63% | $19.13B | +70.94% | 0.77% |
MGPI | 0.64% | $636.24M | -60.94% | 1.58% |
AVAL | 0.66% | $1.09B | +31.51% | 4.15% |
EGO | -0.69% | $4.21B | +23.18% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CERS | 40.07% | $277.18M | -35.56% | 0.00% |
ORGO | 38.72% | $569.57M | +55.36% | 0.00% |
ARCT | 36.40% | $360.98M | -43.07% | 0.00% |
NCZ | 34.84% | - | - | 7.01% |
COGT | 33.82% | $1.55B | +19.89% | 0.00% |
RGNX | 33.46% | $438.38M | -32.40% | 0.00% |
CRBU | 33.32% | $158.11M | -20.19% | 0.00% |
VYGR | 33.06% | $189.80M | -61.72% | 0.00% |
ARWR | 32.93% | $2.57B | -35.52% | 0.00% |
FATE | 32.47% | $130.68M | -70.69% | 0.00% |
ACIU | 32.46% | $205.80M | -43.63% | 0.00% |
WFG | 32.36% | $5.98B | -0.89% | 1.69% |
AMRX | 31.90% | $2.64B | +14.09% | 0.00% |
NTLA | 31.84% | $1.24B | -54.06% | 0.00% |
MGNX | 31.84% | $99.68M | -67.29% | 0.00% |
SYRE | 31.58% | $990.40M | -43.02% | 0.00% |
BEAM | 31.53% | $2.13B | -17.37% | 0.00% |
INSG | 31.52% | $115.11M | -37.44% | 0.00% |
NNOX | 31.05% | $328.37M | -42.00% | 0.00% |
NXST | 30.81% | $5.55B | +6.24% | 3.85% |
Yahoo
INTU, NTGR, PBYI and DASH make the cut as top liquid stocks, with each boasting strong liquidity, growth attributes and operational efficiency.
Yahoo
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Puma Biotech (PBYI) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Yahoo
AstraZeneca secures EU approval for Imfinzi in muscle-invasive bladder cancer, expanding its cancer treatment portfolio.
Finnhub
LOS ANGELES - Puma Biotechnology, Inc. , a biopharmaceutical company, announced that on July 1, 2025, the Compensation Committee of Puma's Board of Directors approved the grant of inducement...
Yahoo
LOS ANGELES, July 02, 2025--Puma Biotechnology reported inducement restricted stock units awarded to new hires in June 2025, as required by Nasdaq Listing Rule 5635(c)(4).
Yahoo
VRTX secures EU approval for Alyftrek, a next-in-class triple combination regimen for treating people with CF aged six years and older.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LITB | -21.13% | $25.36M | -69.22% | 0.00% |
K | -15.98% | $27.64B | +41.46% | 2.87% |
CYCN | -8.88% | $10.59M | +13.01% | 0.00% |
TASK | -8.75% | $1.53B | +8.57% | 0.00% |
AEP | -8.47% | $56.10B | +15.48% | 3.51% |
GFI | -7.11% | $21.69B | +51.82% | 2.28% |
CLMT | -6.94% | $1.42B | +0.31% | 0.00% |
FE | -6.68% | $23.35B | +4.12% | 4.24% |
NOC | -6.68% | $75.00B | +20.65% | 1.63% |
SSL | -6.61% | $3.27B | -28.81% | 0.00% |
CNTY | -6.51% | $73.95M | -7.31% | 0.00% |
MRX | -6.36% | $2.77B | +92.10% | 1.45% |
VSA | -6.21% | $12.16M | +21.20% | 0.00% |
CIG.C | -6.07% | $2.59B | +19.25% | 0.00% |
DV | -5.78% | $2.43B | -25.16% | 0.00% |
PULM | -5.51% | $23.92M | +218.89% | 0.00% |
TKC | -5.43% | $5.05B | -28.34% | 5.52% |
API | -5.14% | $288.93M | +59.02% | 0.00% |
PPC | -4.81% | $10.68B | +32.81% | 0.00% |
DFDV | -4.26% | $361.15M | +2,667.20% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXM | -23.92% | $22.99M | 0.85% |
VIXY | -20.34% | $200.94M | 0.85% |
TFLO | -20.20% | $6.73B | 0.15% |
BTAL | -17.85% | $310.24M | 1.43% |
TAIL | -17.73% | $94.90M | 0.59% |
XHLF | -11.12% | $1.73B | 0.03% |
ULST | -10.55% | $592.71M | 0.2% |
TBLL | -9.25% | $2.12B | 0.08% |
CLIP | -8.30% | $1.51B | 0.07% |
BIL | -7.98% | $41.78B | 0.1356% |
TPMN | -7.86% | $30.86M | 0.65% |
GSST | -7.70% | $925.21M | 0.16% |
SGOV | -7.68% | $50.94B | 0.09% |
GBIL | -7.63% | $6.37B | 0.12% |
BSCP | -7.53% | $3.25B | 0.1% |
USFR | -7.35% | $18.61B | 0.15% |
IBTF | -6.34% | $1.98B | 0.07% |
FXY | -6.17% | $798.58M | 0.4% |
CTA | -5.75% | $1.07B | 0.76% |
IBDQ | -5.70% | $2.96B | 0.1% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GNOM | 40.78% | $45.27M | 0.5% |
XBI | 40.29% | $5.19B | 0.35% |
IBB | 38.08% | $5.59B | 0.45% |
PINK | 37.58% | $132.39M | 0.5% |
PBE | 36.84% | $233.59M | 0.58% |
IWC | 36.01% | $846.53M | 0.6% |
BBH | 35.08% | $345.62M | 0.35% |
ARKG | 35.00% | $1.10B | 0.75% |
IWM | 33.19% | $67.25B | 0.19% |
GSSC | 33.14% | $597.16M | 0.2% |
FBT | 32.98% | $1.05B | 0.54% |
IWO | 32.88% | $11.96B | 0.24% |
VTWO | 32.78% | $12.69B | 0.07% |
PSC | 32.54% | $786.25M | 0.38% |
RDTE | 32.27% | $140.25M | 0.97% |
PTH | 32.23% | $97.64M | 0.6% |
KJUL | 31.97% | $160.44M | 0.79% |
IWN | 31.50% | $11.18B | 0.24% |
SCHA | 31.34% | $17.85B | 0.04% |
CPRJ | 31.33% | $52.57M | 0.69% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
MSOS | 0.01% | $396.48M | 0.77% |
SPTS | 0.07% | $5.78B | 0.03% |
BAR | -0.26% | $1.11B | 0.1749% |
SGOL | -0.27% | $5.21B | 0.17% |
BOXX | 0.28% | $6.97B | 0.19% |
FMF | -0.31% | $161.67M | 0.95% |
OILK | -0.33% | $72.70M | 0.69% |
GLD | -0.34% | $100.91B | 0.4% |
IBD | -0.36% | $391.63M | 0.43% |
IAU | -0.37% | $47.18B | 0.25% |
USL | -0.38% | $43.14M | 0.85% |
DBO | -0.40% | $228.22M | 0.77% |
OUNZ | -0.42% | $1.74B | 0.25% |
COM | 0.47% | $210.46M | 0.72% |
IVOL | 0.50% | $341.06M | 1.02% |
AAAU | -0.52% | $1.56B | 0.18% |
SOYB | 0.55% | $26.41M | 0.22% |
GSG | -0.59% | $1.01B | 0.75% |
UDN | 0.60% | $147.26M | 0.78% |
GLDM | -0.61% | $15.87B | 0.1% |
Current Value
$3.531 Year Return
Current Value
$3.531 Year Return